498 related articles for article (PubMed ID: 27465071)
1. Clinical-Grade Human Multipotent Adult Progenitor Cells Block CD8+ Cytotoxic T Lymphocytes.
Plessers J; Dekimpe E; Van Woensel M; Roobrouck VD; Bullens DM; Pinxteren J; Verfaillie CM; Van Gool SW
Stem Cells Transl Med; 2016 Dec; 5(12):1607-1619. PubMed ID: 27465071
[TBL] [Abstract][Full Text] [Related]
2. Solution-Phase Crosstalk and Regulatory Interactions Between Multipotent Adult Progenitor Cells and Peripheral Blood Mononuclear Cells.
Burrows GG; Van't Hof W; Reddy AP; Wilmarth PA; David LL; Raber A; Bogaerts A; Timmerman L; Pinxteren J; Roobrouck VD; Deans RJ; Maziarz RT
Stem Cells Transl Med; 2015 Dec; 4(12):1436-49. PubMed ID: 26494783
[TBL] [Abstract][Full Text] [Related]
3. Human multipotent adult progenitor cells are nonimmunogenic and exert potent immunomodulatory effects on alloreactive T-cell responses.
Jacobs SA; Pinxteren J; Roobrouck VD; Luyckx A; van't Hof W; Deans R; Verfaillie CM; Waer M; Billiau AD; Van Gool SW
Cell Transplant; 2013; 22(10):1915-28. PubMed ID: 23031260
[TBL] [Abstract][Full Text] [Related]
4. Mutual interaction between human multipotent adult progenitor cells and NK cells.
Jacobs SA; Plessers J; Pinxteren J; Roobrouck VD; Verfaillie CM; Van Gool SW
Cell Transplant; 2014; 23(9):1099-110. PubMed ID: 23562064
[TBL] [Abstract][Full Text] [Related]
5. Clinical-grade multipotent adult progenitor cells durably control pathogenic T cell responses in human models of transplantation and autoimmunity.
Reading JL; Yang JH; Sabbah S; Skowera A; Knight RR; Pinxteren J; Vaes B; Allsopp T; Ting AE; Busch S; Raber A; Deans R; Tree TI
J Immunol; 2013 May; 190(9):4542-52. PubMed ID: 23547116
[TBL] [Abstract][Full Text] [Related]
6. IL-15 induces unspecific effector functions in human peptide-specific CD8+ T-cell cultures.
Lyngstrand ST; Würtzen PA; Ødum N; Nissen MH; Röpke C
Scand J Immunol; 2002 Dec; 56(6):602-10. PubMed ID: 12472672
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells.
Rasmusson I; Ringdén O; Sundberg B; Le Blanc K
Transplantation; 2003 Oct; 76(8):1208-13. PubMed ID: 14578755
[TBL] [Abstract][Full Text] [Related]
8. Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens.
Angoulvant D; Clerc A; Benchalal S; Galambrun C; Farre A; Bertrand Y; Eljaafari A
Biorheology; 2004; 41(3-4):469-76. PubMed ID: 15299278
[TBL] [Abstract][Full Text] [Related]
9. Comparative transcriptome analysis of embryonic and adult stem cells with extended and limited differentiation capacity.
Ulloa-Montoya F; Kidder BL; Pauwelyn KA; Chase LG; Luttun A; Crabbe A; Geraerts M; Sharov AA; Piao Y; Ko MS; Hu WS; Verfaillie CM
Genome Biol; 2007; 8(8):R163. PubMed ID: 17683608
[TBL] [Abstract][Full Text] [Related]
10. Characterization of anti-CD8-resistant cytolytic T lymphocytes induced by multivalent cross-linking of CD8 on precursor cells.
McCarthy SA; Kaldjian E; Singer A
J Immunol; 1989 Oct; 143(7):2112-9. PubMed ID: 2528588
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium tuberculosis multidrug resistant strain M induces an altered activation of cytotoxic CD8+ T cells.
Geffner L; Basile JI; Yokobori N; Kviatcovsky D; Sabio y García C; Ritacco V; López B; Sasiain Mdel C; de la Barrera S
PLoS One; 2014; 9(5):e97837. PubMed ID: 24836916
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.
Selmani Z; Naji A; Zidi I; Favier B; Gaiffe E; Obert L; Borg C; Saas P; Tiberghien P; Rouas-Freiss N; Carosella ED; Deschaseaux F
Stem Cells; 2008 Jan; 26(1):212-22. PubMed ID: 17932417
[TBL] [Abstract][Full Text] [Related]
13. Generation of IL-2-dependent cytolytic T lymphocytes (CTLs) with altered TCR responses derived from antigen-dependent CTL clones.
Gullo CA; Esser MT; Fuller CL; Lam Braciale V
J Immunol; 1999 Jun; 162(11):6466-72. PubMed ID: 10352261
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic characterization of the post-thymic differentiation of human alloantigen-specific CD8+ cytotoxic T lymphocytes.
Yamashita N; Clement LT
J Immunol; 1989 Sep; 143(5):1518-23. PubMed ID: 2474603
[TBL] [Abstract][Full Text] [Related]
15. Multipotent adult germ-line stem cells, like other pluripotent stem cells, can be killed by cytotoxic T lymphocytes despite low expression of major histocompatibility complex class I molecules.
Dressel R; Guan K; Nolte J; Elsner L; Monecke S; Nayernia K; Hasenfuss G; Engel W
Biol Direct; 2009 Aug; 4():31. PubMed ID: 19715575
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated inhibition of proliferation and activation of alloreactive cytotoxic lymphocytes: maintenance of response potential of precursors and dissociation between proliferation and effector function of activated cytotoxic lymphocytes.
Stout RD; Suttles J; Persiani DM; Bakke O
Cell Immunol; 1986 Aug; 101(1):105-21. PubMed ID: 2943413
[TBL] [Abstract][Full Text] [Related]
17. T cells expressing the activating NK-cell receptors KIR2DS4, NKG2C and NKG2D are elevated in paroxysmal nocturnal hemoglobinuria and cytotoxic toward hematopoietic progenitor cell lines.
van Bijnen ST; Withaar M; Preijers F; van der Meer A; de Witte T; Muus P; Dolstra H
Exp Hematol; 2011 Jul; 39(7):751-62.e1-3. PubMed ID: 21554925
[TBL] [Abstract][Full Text] [Related]
18. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
[TBL] [Abstract][Full Text] [Related]
19. Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trial.
Maziarz RT; Devos T; Bachier CR; Goldstein SC; Leis JF; Devine SM; Meyers G; Gajewski JL; Maertens J; Deans RJ; Van't Hof W; Lazarus HM
Biol Blood Marrow Transplant; 2015 Apr; 21(4):720-8. PubMed ID: 25555450
[TBL] [Abstract][Full Text] [Related]
20. CD8high (CD57+) T cells in normal, healthy individuals specifically suppress the generation of cytotoxic T lymphocytes to Epstein-Barr virus-transformed B cell lines.
Wang EC; Lehner PJ; Graham S; Borysiewicz LK
Eur J Immunol; 1994 Nov; 24(11):2903-9. PubMed ID: 7525311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
